Your browser doesn't support javascript.
loading
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Reustle, Anna; Di Marco, Moreno; Meyerhoff, Carolin; Nelde, Annika; Walz, Juliane S; Winter, Stefan; Kandabarau, Siahei; Büttner, Florian; Haag, Mathias; Backert, Linus; Kowalewski, Daniel J; Rausch, Steffen; Hennenlotter, Jörg; Stühler, Viktoria; Scharpf, Marcus; Fend, Falko; Stenzl, Arnulf; Rammensee, Hans-Georg; Bedke, Jens; Stevanovic, Stefan; Schwab, Matthias; Schaeffeler, Elke.
Afiliação
  • Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Di Marco M; University of Tuebingen, Tuebingen, Germany.
  • Meyerhoff C; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Nelde A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Walz JS; University of Tuebingen, Tuebingen, Germany.
  • Winter S; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Kandabarau S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.
  • Büttner F; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Haag M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.
  • Backert L; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.
  • Kowalewski DJ; iFIT Cluster of Excellence (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tuebingen, Tuebingen, Germany.
  • Rausch S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Hennenlotter J; University of Tuebingen, Tuebingen, Germany.
  • Stühler V; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Scharpf M; University of Tuebingen, Tuebingen, Germany.
  • Fend F; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Stenzl A; University of Tuebingen, Tuebingen, Germany.
  • Rammensee HG; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Bedke J; University of Tuebingen, Tuebingen, Germany.
  • Stevanovic S; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Schwab M; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Schaeffeler E; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.
Genome Med ; 12(1): 32, 2020 03 30.
Article em En | MEDLINE | ID: mdl-32228647
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Genômica / Antígenos HLA / Imunoterapia / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Genômica / Antígenos HLA / Imunoterapia / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article